Thyroid cancer - papillary carcinoma: MedlinePlus Medical Encyclopedia. https://medlineplus.gov/ency/article/000331.htm. Accessed 10 Jul 2023
Cancer Genome Atlas Research Network (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159:676–690. https://doi.org/10.1016/j.cell.2014.09.050
Daniels GH (2011) What if many follicular variant papillary thyroid carcinomas are not malignant? A review of follicular variant papillary thyroid carcinoma and a proposal for a new classification. Endocr Pract 17:768–787. https://doi.org/10.4158/EP10407.RA
Omur O, Baran Y (2014) An update on molecular biology of thyroid cancers. Crit Rev Oncol Hematol 90:233–252. https://doi.org/10.1016/j.critrevonc.2013.12.007
Rangel-Pozzo A, Sisdelli L, Cordioli MIV, Vaisman F, Caria P, Mai S, Cerutti JM (2020) Genetic Landscape of Papillary Thyroid Carcinoma and Nuclear Architecture: An Overview Comparing Pediatric and Adult Populations. Cancers 12:3146. https://doi.org/10.3390/cancers12113146
Article CAS PubMed PubMed Central Google Scholar
Tufano RP, Teixeira GV, Bishop J, Carson KA, Xing M (2012) BRAF Mutation in Papillary Thyroid Cancer and Its Value in Tailoring Initial Treatment: A Systematic Review and Meta-Analysis. Medicine 91:274. https://doi.org/10.1097/MD.0b013e31826a9c71
Article CAS PubMed Google Scholar
Li C, Lee KC, Schneider EB, Zeiger MA (2012) BRAF V600E mutation and Its Association with Clinicopathological Features of Papillary Thyroid Cancer: A Meta-Analysis. The Journal of Clinical Endocrinology & Metabolism 97:4559–4570. https://doi.org/10.1210/jc.2012-2104
Wang Z, Chen J-Q, Liu J-L, Qin X-G (2016) Clinical impact of BRAF mutation on the diagnosis and prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. European Journal of Clinical Investigation 46:146–157. https://doi.org/10.1111/eci.12577
Article CAS PubMed Google Scholar
Song J, Sun S, Dong F, Huang T, Wu B, Zhou J (2018) Predictive Value of BRAFV600E Mutation for Lymph Node Metastasis in Papillary Thyroid Cancer: A Meta-analysis. CURR MED SCI 38:785–797. https://doi.org/10.1007/s11596-018-1945-7
Article CAS PubMed Google Scholar
Wei X, Wang X, Xiong J, Li C, Liao Y, Zhu Y, Mao J (2022) Risk and Prognostic Factors for BRAFV600E Mutations in Papillary Thyroid Carcinoma. Biomed Res Int 2022:9959649. https://doi.org/10.1155/2022/9959649
Article PubMed PubMed Central Google Scholar
Li X, Kwon H (2020) The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis. Cancers (Basel) 12:2056. https://doi.org/10.3390/cancers12082056
Article CAS PubMed Google Scholar
DeLellis R, Lloyd R, Heitz P, Eng C Pathology and Genetics of Tumours of Endocrine Organs, 3rd ed. International Agency for Research on Cancer, Lyon, France
Shi X, Liu R, Basolo F, Giannini R, Shen X, Teng D, Guan H, Shan Z, Teng W, Musholt TJ, Al-Kuraya K, Fugazzola L, Colombo C, Kebebew E, Jarzab B, Czarniecka A, Bendlova B, Sykorova V, Sobrinho-Simões M, Soares P, Shong YK, Kim TY, Cheng S, Asa SL, Viola D, Elisei R, Yip L, Mian C, Vianello F, Wang Y, Zhao S, Oler G, Cerutti JM, Puxeddu E, Qu S, Wei Q, Xu H, O’Neill CJ, Sywak MS, Clifton-Bligh R, Lam AK, Riesco-Eizaguirre G, Santisteban P, Yu H, Tallini G, Holt EH, Vasko V, Xing M (2016) Differential Clinicopathological Risk and Prognosis of Major Papillary Thyroid Cancer Variants. J Clin Endocrinol Metab 101:264–274. https://doi.org/10.1210/jc.2015-2917
Article CAS PubMed Google Scholar
Lloyd R, Osamura R, Klöppel G, Rosai J WHO Classification of Tumours of Endocrine Organs, 4th ed. International Agency for Research on Cancer, Lyon, France
Nath MC, Erickson LA (2018) Aggressive Variants of Papillary Thyroid Carcinoma: Hobnail, Tall Cell, Columnar, and Solid. Adv Anat Pathol 25:172–179. https://doi.org/10.1097/PAP.0000000000000184
Article CAS PubMed Google Scholar
Dettmer MS, Schmitt A, Steinert H, Capper D, Moch H, Komminoth P, Perren A (2015) Tall cell papillary thyroid carcinoma: new diagnostic criteria and mutations in BRAF and TERT. Endocr Relat Cancer 22:419–429. https://doi.org/10.1530/ERC-15-0057
Article CAS PubMed Google Scholar
Ganly I, Ibrahimpasic T, Rivera M, Nixon I, Palmer F, Patel SG, Tuttle RM, Shah JP, Ghossein R (2014) Prognostic implications of papillary thyroid carcinoma with tall-cell features. Thyroid 24:662–670. https://doi.org/10.1089/thy.2013.0503
Article CAS PubMed Google Scholar
Seethala RR, Baloch ZW, Barletta JA, Khanafshar E, Mete O, Sadow PM, LiVolsi VA, Nikiforov YE, Tallini G, Thompson LD (2018) Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a review for pathologists. Modern Pathology 31:39–55. https://doi.org/10.1038/modpathol.2017.130
Article CAS PubMed Google Scholar
Johnson DN, Furtado LV, Long BC, Zhen CJ, Wurst M, Mujacic I, Kadri S, Segal JP, Antic T, Cipriani NA (2018) Noninvasive Follicular Thyroid Neoplasms With Papillary-like Nuclear Features Are Genetically and Biologically Similar to Adenomatous Nodules and Distinct From Papillary Thyroid Carcinomas With Extensive Follicular Growth. Arch Pathol Lab Med 142:838–850. https://doi.org/10.5858/arpa.2017-0118-OA
Article CAS PubMed Google Scholar
(2022) WHO Classification of Tumours Editorial Board: Endocrine and Neuroendocrine tumours, 5th ed. International Agency for Research on Cancer, Lyon, France
Ferris RL, Baloch Z, Bernet V, Chen A, Fahey TJ, Ganly I, Hodak SP, Kebebew E, Patel KN, Shaha A, Steward DL, Tufano RP, Wiseman SM, Carty SE (2015) American Thyroid Association Statement on Surgical Application of Molecular Profiling for Thyroid Nodules: Current Impact on Perioperative Decision Making. Thyroid 25:760–768. https://doi.org/10.1089/thy.2014.0502
Article PubMed PubMed Central Google Scholar
Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L (2016) 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 26:1–133. https://doi.org/10.1089/thy.2015.0020
Article PubMed PubMed Central Google Scholar
Simpson WJ, McKinney SE, Carruthers JS, Gospodarowicz MK, Sutcliffe SB, Panzarella T (1987) Papillary and follicular thyroid cancer. Prognostic factors in 1,578 patients. Am J Med 83:479–488. https://doi.org/10.1016/0002-9343(87)90758-3
Article CAS PubMed Google Scholar
Schindler AM, van Melle G, Evequoz B, Scazziga B (1991) Prognostic factors in papillary carcinoma of the thyroid. Cancer 68:324–330. https://doi.org/10.1002/1097-0142(19910715)68:2<324::aid-cncr2820680220>3.0.co;2-s
Article CAS PubMed Google Scholar
Mazzaferri EL, Jhiang SM (1994) Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer. Am J Med 97:418–428. https://doi.org/10.1016/0002-9343(94)90321-2
Article CAS PubMed Google Scholar
Zhan L, Feng H, Yu X, Li L, Song J, Tu Y, Yuan J, Chen C, Sun S (2022) Clinical and prognosis value of the number of metastatic lymph nodes in patients with papillary thyroid carcinoma. BMC Surg 22:235. https://doi.org/10.1186/s12893-022-01635-7
Article PubMed PubMed Central Google Scholar
Lee CW, Roh J-L, Gong G, Cho K-J, Choi S-H, Nam SY, Kim SY (2015) Risk factors for recurrence of papillary thyroid carcinoma with clinically node-positive lateral neck. Ann Surg Oncol 22:117–124. https://doi.org/10.1245/s10434-014-3900-6
Hong YR, Lee SH, Lim DJ, Kim MH, Jung CK, Chae BJ, Song BJ, Bae JS (2017) The stratification of patient risk depending on the size and ratio of metastatic lymph nodes in papillary thyroid carcinoma. World J Surg Oncol 15:74. https://doi.org/10.1186/s12957-017-1141-4
Article PubMed PubMed Central Google Scholar
Parker KG, White MG, Cipriani NA (2020) Comparison of Molecular Methods and BRAF Immunohistochemistry (VE1 Clone) for the Detection of BRAF V600E Mutation in Papillary Thyroid Carcinoma: A Meta-Analysis. Head Neck Pathol 14:1067–1079. https://doi.org/10.1007/s12105-020-01166-8
Article PubMed PubMed Central Google Scholar
Kadri S, Long BC, Mujacic I, Zhen CJ, Wurst MN, Sharma S, McDonald N, Niu N, Benhamed S, Tuteja JH, Seiwert TY, White KP, McNerney ME, Fitzpatrick C, Wang YL, Furtado LV, Segal JP (2017) Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. J Mol Diagn 19:43–56. https://doi.org/10.1016/j.jmoldx.2016.07.012
Comments (0)